Clinical trial
LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide and Tirzepatide Therapy (LEAN-PREP Study)
NCT06885736 is registered in ClinicalTrials.gov with Dasman Diabetes Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide and Tirzepatide Therapy (LEAN-PREP Study)
- Lead sponsor
- Dasman Diabetes Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 7, 2025
- Completion date
- December 31, 2029
- Enrollment
- 232 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.